Biotech

All Articles

Novo inks $600M NanoVation deal to examine hereditary medications ex-liver

.Novo Nordisk is actually continuing its own press into hereditary medications, agreeing to pay Nano...

Innovent web links cytokine to intestines cancer reactions

.Innovent Biologics has produced the situation that its gate inhibitor-cytokine combination protein ...

Merck, Daiichi ADC attacks objective in stage 3 lung cancer research

.A stage 3 trial of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugate...

Rakovina strengthens AI center along with collab to select cancer targets

.Five months after Rakovina Rehabs rotated toward artificial intelligence, the cancer-focused biotec...

Ascendis' dwarfism drug hits in stage 3, threatens BioMarin

.Ascendis Pharma has become a possible hazard to BioMarin's Voxzogo, reporting period 3 development ...

Despite ph. 3 miss out on, Alkeus views course ahead of time for eye condition resource

.Though Alkeus Pharmaceuticals' oral eye ailment asset neglected to dramatically minimize geographic...

Kairos goes public with $6M IPO to cash trials of cancer medication

.Along with a trio of biotechs attacking the Nasdaq on Friday, it was quick and easy to miss a small...

Vaccine and also Keytruda combo efficient in squamous tissue carcinoma

.Invulnerable gate preventions are the superheroes of cancer cells treatment. Drugs like Bristol Mye...

Cue Biopharma queues up J&ampJ vet as CBO-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of substantial management hirings, firings as we...

Regeneron's Opdualag rival shows 57% reaction cost

.Regeneron is back along with long-lasting consequence for its own LAG-3 prevention and also PD-1 pr...